I de la Gándara - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

I de la Gándara

Showing results (1-10 of 9) with videos related to

Pageof 1

Sort By:

Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1993

[Bearable truth as the crux of information for the cancer patient]E Espinosa, M González Barón, J Poveda, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1997

Pericardial tamponade as the first manifestation of adenocarcinomaI de la Gándara, E Espinosa, J Gómez Cerezo, et al.

Revista Clinica Espanola|April 1, 1991

[Descriptive study of the care of oncologic patients at the emergency service of a general hospital]A Artal, P Garrido, A Berrocal, et al.

International Orthopaedics|January 1, 1991

Bone metastases as the first manifestation of a tumourM G Barón, I de la Gándara, E Espinosa, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|January 1, 1991

[Primary multicentric cerebral lymphoma in a previously healthy patient]J C Medraño, J Gómez Cerezo, I de la Gándara, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994

Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative GroupM González Barón, J Feliu, E Espinosa, et al.

Cancer|October 20, 1999

Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative GroupJ Feliu, L López Gómez, C Madroñal, et al.

European Journal of Cancer (Oxford, England : 1990)|December 1, 1995

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyM González-Barón, J Feliu, I de la Gándara, et al.

Cancer|May 15, 1997

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative GroupJ Feliu, M González Barón, E Espinosa, et al.

Pageof 1

Search research articles

Showing results (1-10 of 9) with videos related to

Sort By:

Pageof 1

Anales De Medicina Interna (Madrid, Spain : 1984)|March 1, 1993

[Bearable truth as the crux of information for the cancer patient]E Espinosa, M González Barón, J Poveda, et al.

Acta Oncologica (Stockholm, Sweden)|January 1, 1997

Pericardial tamponade as the first manifestation of adenocarcinomaI de la Gándara, E Espinosa, J Gómez Cerezo, et al.

Revista Clinica Espanola|April 1, 1991

[Descriptive study of the care of oncologic patients at the emergency service of a general hospital]A Artal, P Garrido, A Berrocal, et al.

International Orthopaedics|January 1, 1991

Bone metastases as the first manifestation of a tumourM G Barón, I de la Gándara, E Espinosa, et al.

Anales De Medicina Interna (Madrid, Spain : 1984)|January 1, 1991

[Primary multicentric cerebral lymphoma in a previously healthy patient]J C Medraño, J Gómez Cerezo, I de la Gándara, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1994

Comparison of two chemotherapeutic regimens--mitomycin + vindesine + cisplatin (MVP) vs. mitomycin + ifosfamide + cisplatin (MIP)--in advanced non-small-cell lung cancer. ONCOPAZ Cooperative GroupM González Barón, J Feliu, E Espinosa, et al.

Cancer|October 20, 1999

Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin. Oncopaz Cooperative GroupJ Feliu, L López Gómez, C Madroñal, et al.

European Journal of Cancer (Oxford, England : 1990)|December 1, 1995

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II studyM González-Barón, J Feliu, I de la Gándara, et al.

Cancer|May 15, 1997

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative GroupJ Feliu, M González Barón, E Espinosa, et al.

Pageof 1